Rapid Rx Quiz: GLP-1 Agonists

Mary L. Windle, PharmD


May 03, 2023

Pharmacologic blood sugar control and weight loss therapies have recently seen several newly approved products. These include glucagon-like peptide 1 (GLP-1) agonists, which have received interest from clinicians, patients, and the general public alike. This drug class is now often used by those who are not facing true weight-management issues and among patients without diabetes, as they are approved and intended. How much do you know about GLP-1 agonists such as semaglutide and tirzepatide? Make sure you know key indications, contraindications, and adverse events for these increasingly popular drugs with this short quiz.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.